Inventor
MCCALL JOHN M
US85 patents
⚠️ This page may combine multiple inventors who share the name “MCCALL JOHN M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
UPJOHN CO
22 patentsUS5380839AJan 10, 1995
Phenylpiperazinyl steroids
UPJOHN CO54 citations95
US4771042ASep 13, 1988
Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
UPJOHN CO87 citations94
US4159331AJun 26, 1979
Antihypertensive 4-aminoquinolines
UPJOHN CO35 citations93
US5120843AJun 9, 1992
Pharmaceutically active amines
UPJOHN CO44 citations92
US5175281ADec 29, 1992
Pharmaceutically active pyrimidinylpiperazinylsterioids
UPJOHN CO30 citations91
US4329459AMay 11, 1982
Tetrahydrobenzopyran derivatives
UPJOHN CO25 citations82
US4287338ASep 1, 1981
Sulfooxy-pyrimidinium, -pyridinium, and -triazinium hydroxide inner salts
UPJOHN CO21 citations82
US4167567ASep 11, 1979
Antihypertensive 4-aminoquinolines
UPJOHN CO28 citations82
US4166853ASep 4, 1979
Antihypertensive 7-trifluoromethyl-4-aminoquinolones
UPJOHN CO21 citations82
US4153612AMay 8, 1979
2-Benzoxepins
UPJOHN CO22 citations82
US4948533AAug 14, 1990
11a-hydroxy steroid diester
UPJOHN CO20 citations80
US5382661AJan 17, 1995
Pyrazinylpiperazinyl steroids
UPJOHN CO7 citations74
US4556656ADec 3, 1985
2-Benzoxepins
UPJOHN CO15 citations74
US4247553AJan 27, 1981
Methods of treating psychosis
UPJOHN CO13 citations74
US4207239AJun 10, 1980
Benzothiepins
UPJOHN CO11 citations74
US4179510ADec 18, 1979
Methods of treating psychosis
UPJOHN CO16 citations74
US4140775AFeb 20, 1979
Piperazino methyl phenyl aminoquinolines
UPJOHN CO9 citations74
US5506354AApr 9, 1996
Imidazolylpiperazinyl steroids
UPJOHN CO8 citations73
US5380841AJan 10, 1995
Pyridinylpiperazinyl steroids
UPJOHN CO6 citations73
US5268477ADec 7, 1993
Triazinylpiperazinyl amine intermediates
UPJOHN CO9 citations73
US5322943AJun 21, 1994
Piperazine compounds which are substituted
UPJOHN CO7 citations72
US5099019AMar 24, 1992
Amines useful in producing pharmaceutically active CNS compounds
UPJOHN CO12 citations72
MCCALL JOHN M
8 patentsUS8334279B2Dec 18, 2012
Non-hormonal steroid modulators of NF-κB for treatment of disease
MCCALL JOHN M10 citations92
US8207151B2Jun 26, 2012
Non-hormonal steroid modulators of NF-κB for treatment of disease
MCCALL JOHN M13 citations92
US4251526AFeb 17, 1981
2-Benzothiepins and compositions and methods of use therefore
MCCALL JOHN M40 citations92
US9198921B2Dec 1, 2015
Non-hormonal steroid modulators of NF-κB for treatment of disease
MCCALL JOHN M11 citations84
US8916560B2Dec 23, 2014
Heterocyclic compounds for the inhibition of PASK
MCCALL JOHN M6 citations84
US9073902B2Jul 7, 2015
Substituted quinoxaline carboxylic acid compounds for the inhibition of PASK
MCCALL JOHN M5 citations73
US8916561B2Dec 23, 2014
Substituted quinoxaline compounds for the inhibition of PASK
MCCALL JOHN M5 citations73
US8912188B2Dec 16, 2014
Substituted quinoxaline carboxylic acids for the inhibition of PASK
MCCALL JOHN M6 citations73
REVERAGEN BIOPHARMA INC
7 patentsUS9649320B2May 16, 2017
Non-hormonal steroid modulators of NF-κB for treatment of disease
REVERAGEN BIOPHARMA INC8 citations92
US9434758B2Sep 6, 2016
Non-hormonal steroid modulators of NF-κB for treatment of disease
REVERAGEN BIOPHARMA INC8 citations92
US10857161B2Dec 8, 2020
Non-hormonal steroid modulators of NF-kB for treatment of disease
REVERAGEN BIOPHARMA INC6 citations84
US10206933B2Feb 19, 2019
Non-hormonal steroid modulators of NF-kB for treatment of disease
REVERAGEN BIOPHARMA INC7 citations84
US10799514B2Oct 13, 2020
Non-hormonal steroid modulators of NF-kappa beta for treatment of disease
REVERAGEN BIOPHARMA INC6 citations83
US10464967B2Nov 5, 2019
Non-hormonal steroid modulators of NF-κβ for treatment of disease
REVERAGEN BIOPHARMA INC7 citations79
US11833159B2Dec 5, 2023
Non-hormonal steroid modulators of NF-kB for treatment of disease
REVERAGEN BIOPHARMA INC1 citations73
IMAGO BIOSCIENCES INC
7 patentsUS9981922B2May 29, 2018
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC11 citations91
US11230534B2Jan 25, 2022
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC4 citations83
US10882835B2Jan 5, 2021
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC6 citations83
US10519118B2Dec 31, 2019
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC8 citations83
US10370346B2Aug 6, 2019
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC7 citations83
US9790195B2Oct 17, 2017
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC10 citations79
US11655226B2May 23, 2023
KDM1A inhibitors for the treatment of disease
IMAGO BIOSCIENCES INC1 citations72
BIOENERGENIX LLC
3 patentsUS9193693B2Nov 24, 2015
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC4 citations83
US10781185B2Sep 22, 2020
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC1 citations72
US9868708B2Jan 16, 2018
Heterocyclic compounds for the inhibition of PASK
BIOENERGENIX LLC3 citations72
VALIDUS GENETICS
1 patentRAJE PRASAD
1 patentKNOPP BIOSCIENCES LLC
1 patentShowing the top 50 of 85 patents by PatentIndex Score.